Sign in

CIK 0001812364

  • Large accelerated filer

Relay Therapeutics, Inc.

Sign in to watch
Ticker
RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-370-8837
Business address
60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Planned sale See remarks sold 80,909 shares at an average $4.27 ($345,572)
  7. 4 Open-market sale Chief Legal Officer sold 299 shares at $4.38 ($1,310)
  8. 4 Open-market sale President, R&D sold 657 shares at $4.38 ($2,878)
  9. 4 Planned sale Chief Financial Officer sold 4,865 shares at an average $4.42 ($21,491)
  10. 4 Open-market sale See remarks sold 400 shares at $4.38 ($1,752)
  11. 4 Planned sale President and CEO sold 100,000 shares at $5.00 ($500,000)
  12. 4 Open-market sale See remarks sold 1,621 shares at $6.06 ($9,823)
  13. 4 Planned sale Chief Financial Officer sold 9,102 shares at an average $6.03 ($54,905)
  14. 4 Open-market sale President, R&D sold 2,688 shares at $6.06 ($16,289)
  15. 4 Open-market sale Chief Legal Officer sold 1,632 shares at $6.06 ($9,890)
  16. 4 Open-market sale See remarks sold 245 shares at $7.51 ($1,840)
  17. 4 Planned sale Chief Financial Officer sold 6,457 shares at an average $7.46 ($48,184)
  18. 4 Open-market sale President, R&D sold 648 shares at $7.51 ($4,866)
  19. 4 Open-market sale Chief Legal Officer sold 295 shares at $7.51 ($2,215)
  20. 4 Planned sale Chief Financial Officer sold 10,780 shares at an average $8.56 ($92,316)

Page 5 of 16 · 320 filings